BURDEN OF DISEASE FOR RHEUMATOID ARTHRITIS IN ARGENTINA, BRAZIL, COLOMBIA, MEXICO AND VENEZUELA

Author(s)

Papadimitropoulos M¹, Castelar G², Brnabic A³, Vorstenbosch EC⁴, Garcia EG⁵, Botello BS⁵, Hernandez P⁶, Goncalves L⁷, Gaich CL⁸
¹Eli Lilly and Company, Canada; University of Toronto, Toronto, ON, Canada, ²Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, ³Eli Lilly and Company, Sydney, Australia, ⁴Parc Sanitari Sant Joan de Deu, Barcelona, Spain, ⁵Eli Lilly and Company, Mexico City, Mexico, ⁶Compañía Farmacéutica Eli Lilly de Centroamérica, S.A, Este San José, Costa Rica, ⁷Eli Lilly and Company, São Paulo, Brazil, ⁸Eli Lilly and Company, Indianapolis, IN, USA

OBJECTIVES: Rheumatoid arthritis (RA) is a chronic autoimmune disease which, when left untreated, may result in the destruction of multiple joints. The condition also can damage a wide variety of body systems, including the skin, eyes, lungs, heart and blood vessels. The objective of this study is to conduct a systematic review on disease burden for RA in five Latin-American countries, namely Argentina, Brazil, Colombia, Mexico and Venezuela.

METHODS: PubMed/Medline, Embase, Web of Science and grey literature databases (BASE, SciELO and PDF Search Engine) were searched for publications in English, Spanish or Portuguese at November 10^{thThe AMSTAR quality criteria were taken into account.}

RESULTS: A total of 1585 records were retrieved. The Global Burden of Disease initiative 2015 estimated that RA accounted for 0.26% of World Disability Adjusted Life Years (DALY's). For Latin America, these figures were higher: Argentina 0.63%, Brazil 0.33%, Colombia 0.51%, Mexico CONCLUSIONS: The burden of RA in Latin America is large. However, evidence is still scarce and more studies are needed to evaluate the full cost and impact of the disease in Latin American countries.

Conference/Value in Health Info

2017-09, ISPOR Latin America 2017, Sao Paulo, Brazil

Value in Health, Vol. 20, No. 9 (October 2017)

Code

PSY15

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Systemic Disorders/Conditions

Explore Related HEOR by Topic

Economic Evaluation

Presentation